In addition, patients with AITD often develop other organ-specific antibodies, and have higher risk of developing associated conditions such as Addison's disease, premature ovarian failure, chronic hepatitis, celiac disease, primary biliary cirrhosis, pernicious anemia, type 1 diabetes, multiple sclerosis, myasthenia gravis, vitiligo, rheumatoid arthritis, systemic lupus erythematous, systemic sclerosis, idiopathic thrombocytopenic purpura, urticaria, alopecia, and angioedema (212-220)
Injections, topical gels, or pellets: Different delivery methods provide flexibility depending on how hands-on you want treatment to be and how steadily you prefer your hormone levels maintained
B 5 , 285299 (2015)
The enzyme glutathione reductase, which is quite active in red blood cells, carries out this reduction, using NADPH as a reducing agent
LPAR6 inhibits the progression of hepatocellular carcinoma (HCC) by suppressing the nuclear translocation of YAP/TAZ